Effect of FN1 mutation on outcomes of fibronectin glomerulopathy in a systematic review and meta-analysis

Background. Fibronectin glomerulopathy is an inherited kidney disease that is characterized with extensive depositions of fibronectin in mesangium and subendothelial space. The aim of study is to assess effect of fibronectin gene on decreased renal function and likeliness of recurrence of the diseas...

Full description

Bibliographic Details
Main Author: Fateme Shamekhi
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2022-02-01
Series:Počki
Subjects:
Online Access:https://kidneys.zaslavsky.com.ua/index.php/journal/article/view/353
_version_ 1818006312177369088
author Fateme Shamekhi
author_facet Fateme Shamekhi
author_sort Fateme Shamekhi
collection DOAJ
description Background. Fibronectin glomerulopathy is an inherited kidney disease that is characterized with extensive depositions of fibronectin in mesangium and subendothelial space. The aim of study is to assess effect of fibronectin gene on decreased renal function and likeliness of recurrence of the disease after kidney transplantation. Materials and methods. In retrospective descriptive studies, fifty-seven patients with fibronectin glomerulopathy were enrolled in this research. Relative risk and Odds ratio for asses­sing effect measures of risk factor on outcomes of disease were used. Results. Of fifty-seven patients with fibronectin glomerulopathy, thirty-six patients (36/57, 63.1 %) were male and twenty-one patients were female (21/57, 36.8 %). Relative risk and Odds ratio of end-stage kidney disease (ESKD) in nephrotic-range proteinuria versus non-nephrotic range proteinuria were assessed 1.33 and 1.39, respectively. Relative risk and Odds ratio of end-stage kidney disease with kidney replacement therapy (KRT) in patients with positive FN1 gene (as risk or contributing factor) versus patients with negative FN1 gene was assessed 0.66 and 0.50, respectively. Risk of recurrence after kidney transplant with nephrotic-range proteinuria was assessed 0.83 (95% confidence interval of 0.1213 to 5.7244) and odds ratio of recurrence after kidney transplant with nephrotic proteinuria versus non-nephrotic range proteinuria was assessed 0.75 (95% confidence interval of 0.03757 to 14.9733) in the current research. Conclusions. Relative risk and odds ratio of end-stage kidney disease in nephrotic-range proteinuria versus non-nephrotic range proteinuria were assessed 1.33 and 1.39, respectively. Therefore, it appears risk of fibronectin gene 1 on end-stage kidney disease with kidney replacement therapy be low.
first_indexed 2024-04-14T04:59:25Z
format Article
id doaj.art-19414b684bf7432aa8a779b31e924612
institution Directory Open Access Journal
issn 2307-1257
2307-1265
language English
last_indexed 2024-04-14T04:59:25Z
publishDate 2022-02-01
publisher Zaslavsky O.Yu.
record_format Article
series Počki
spelling doaj.art-19414b684bf7432aa8a779b31e9246122022-12-22T02:11:00ZengZaslavsky O.Yu.Počki2307-12572307-12652022-02-011112910.22141/2307-1257.11.1.2022.353353Effect of FN1 mutation on outcomes of fibronectin glomerulopathy in a systematic review and meta-analysisFateme Shamekhi0https://orcid.org/0000-0002-5686-273XImam Khomeini Hospital Complex, National Tehran Medical College, National Tehran of University Medical Sciences, Tehran, IranBackground. Fibronectin glomerulopathy is an inherited kidney disease that is characterized with extensive depositions of fibronectin in mesangium and subendothelial space. The aim of study is to assess effect of fibronectin gene on decreased renal function and likeliness of recurrence of the disease after kidney transplantation. Materials and methods. In retrospective descriptive studies, fifty-seven patients with fibronectin glomerulopathy were enrolled in this research. Relative risk and Odds ratio for asses­sing effect measures of risk factor on outcomes of disease were used. Results. Of fifty-seven patients with fibronectin glomerulopathy, thirty-six patients (36/57, 63.1 %) were male and twenty-one patients were female (21/57, 36.8 %). Relative risk and Odds ratio of end-stage kidney disease (ESKD) in nephrotic-range proteinuria versus non-nephrotic range proteinuria were assessed 1.33 and 1.39, respectively. Relative risk and Odds ratio of end-stage kidney disease with kidney replacement therapy (KRT) in patients with positive FN1 gene (as risk or contributing factor) versus patients with negative FN1 gene was assessed 0.66 and 0.50, respectively. Risk of recurrence after kidney transplant with nephrotic-range proteinuria was assessed 0.83 (95% confidence interval of 0.1213 to 5.7244) and odds ratio of recurrence after kidney transplant with nephrotic proteinuria versus non-nephrotic range proteinuria was assessed 0.75 (95% confidence interval of 0.03757 to 14.9733) in the current research. Conclusions. Relative risk and odds ratio of end-stage kidney disease in nephrotic-range proteinuria versus non-nephrotic range proteinuria were assessed 1.33 and 1.39, respectively. Therefore, it appears risk of fibronectin gene 1 on end-stage kidney disease with kidney replacement therapy be low.https://kidneys.zaslavsky.com.ua/index.php/journal/article/view/353fibronectinfibronectin glomerulopathykidney failurelobular appearance
spellingShingle Fateme Shamekhi
Effect of FN1 mutation on outcomes of fibronectin glomerulopathy in a systematic review and meta-analysis
Počki
fibronectin
fibronectin glomerulopathy
kidney failure
lobular appearance
title Effect of FN1 mutation on outcomes of fibronectin glomerulopathy in a systematic review and meta-analysis
title_full Effect of FN1 mutation on outcomes of fibronectin glomerulopathy in a systematic review and meta-analysis
title_fullStr Effect of FN1 mutation on outcomes of fibronectin glomerulopathy in a systematic review and meta-analysis
title_full_unstemmed Effect of FN1 mutation on outcomes of fibronectin glomerulopathy in a systematic review and meta-analysis
title_short Effect of FN1 mutation on outcomes of fibronectin glomerulopathy in a systematic review and meta-analysis
title_sort effect of fn1 mutation on outcomes of fibronectin glomerulopathy in a systematic review and meta analysis
topic fibronectin
fibronectin glomerulopathy
kidney failure
lobular appearance
url https://kidneys.zaslavsky.com.ua/index.php/journal/article/view/353
work_keys_str_mv AT fatemeshamekhi effectoffn1mutationonoutcomesoffibronectinglomerulopathyinasystematicreviewandmetaanalysis